These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35710078)

  • 41. CD36 and Fyn kinase mediate malaria-induced lung endothelial barrier dysfunction in mice infected with Plasmodium berghei.
    Anidi IU; Servinsky LE; Rentsendorj O; Stephens RS; Scott AL; Pearse DB
    PLoS One; 2013; 8(8):e71010. PubMed ID: 23967147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis.
    Ota C; Ng-Blichfeldt JP; Korfei M; Alsafadi HN; Lehmann M; Skronska-Wasek W; M De Santis M; Guenther A; Wagner DE; Königshoff M
    Sci Rep; 2018 Aug; 8(1):12983. PubMed ID: 30154568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury.
    de Almeida CJ; Jasmin JF; Del Galdo F; Lisanti MP
    Cell Cycle; 2013 Jul; 12(14):2248-54. PubMed ID: 24067367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation.
    Park SJ; Hahn HJ; Oh SR; Lee HJ
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models.
    Kaur R; Shaikh TB; Priya Sripadi H; Kuncha M; Vijaya Sarathi UVR; Kulhari H; Balaji Andugulapati S; Sistla R
    Int J Pharm; 2024 Jan; 649():123644. PubMed ID: 38040396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis.
    Ahangari F; Becker C; Foster DG; Chioccioli M; Nelson M; Beke K; Wang X; Justet A; Adams T; Readhead B; Meador C; Correll K; Lili LN; Roybal HM; Rose KA; Ding S; Barnthaler T; Briones N; DeIuliis G; Schupp JC; Li Q; Omote N; Aschner Y; Sharma L; Kopf KW; Magnusson B; Hicks R; Backmark A; Dela Cruz CS; Rosas I; Cousens LP; Dudley JT; Kaminski N; Downey GP
    Am J Respir Crit Care Med; 2022 Dec; 206(12):1463-1479. PubMed ID: 35998281
    [No Abstract]   [Full Text] [Related]  

  • 49. TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis.
    Chen H; He A; Li H; Chen H; Xie H; Luo L; Huang Y; Chen J; Guan J; He Q; Ma J; Ou C; Tao A; Yan J
    Cell Death Dis; 2021 Oct; 12(10):938. PubMed ID: 34645797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of Sulf2 in idiopathic pulmonary fibrosis.
    Yue X; Lu J; Auduong L; Sides MD; Lasky JA
    Glycobiology; 2013 Jun; 23(6):709-19. PubMed ID: 23418199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
    Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
    PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K
    J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis.
    Lu YZ; He XL; Liu F; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Yu F; Xin JB; Ye H; Song LJ; Ma WL
    Exp Cell Res; 2020 Nov; 396(1):112295. PubMed ID: 32971116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis.
    Su W; Guo Y; Wang Q; Ma L; Zhang Q; Zhang Y; Geng Y; Jin T; Guo J; Yang R; Niu Z; Ren L; Wang Y; Ning Z; Li W; He W; Sun J; Li T; Li Z; Shan H; Liang H
    Exp Mol Med; 2024 Jul; 56(7):1643-1654. PubMed ID: 38945958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs.
    Matsuda S; Kim JD; Sugiyama F; Matsuo Y; Ishida J; Murata K; Nakamura K; Namiki K; Sudo T; Kuwaki T; Hatano M; Tatsumi K; Fukamizu A; Kasuya Y
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic WNT/β-catenin signaling induces cellular senescence in lung epithelial cells.
    Lehmann M; Hu Q; Hu Y; Hafner K; Costa R; van den Berg A; Königshoff M
    Cell Signal; 2020 Jun; 70():109588. PubMed ID: 32109549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
    Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE
    Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.
    Yamada Z; Nishio J; Motomura K; Mizutani S; Yamada S; Mikami T; Nanki T
    Front Immunol; 2022; 13():935114. PubMed ID: 36059455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.